Medications for High Grade Bcell Lymphoma

3 results
  • breyanzi

    (Lisocabtagene Maraleucel)
    Juno Therapeutics, Inc.
    Breyanzi is a CD19-directed CAR-T cell immunotherapy for adults with relapsed or refractory large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle cell lymphoma, or marginal zone lymphoma after 2 or more prior lines of therapy. Not indicated for primary CNS lymphoma.
  • epkinly - epcoritamab - bysp injection, solution

    (Epcoritamab-Bysp)
    Genmab Us, Inc.
    Epkinly treats adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma after 2+ prior therapies. Also indicated for relapsed or refractory follicular lymphoma (FL), with lenalidomide and rituximab or as monotherapy after 2+ prior therapies.
  • yescarta

    (Axicabtagene Ciloleucel)
    Kite Pharma, Inc.
    Yescarta is a CAR-T cell therapy for adults with large B-cell lymphoma refractory to or relapsing after first-line chemoimmunotherapy, or after two or more prior therapies. Also indicated for relapsed or refractory follicular lymphoma after two or more lines of systemic therapy (accelerated approval).